Opus Point Partners Management’s Bristol-Myers Squibb BMY Stock Holding History

Opus Point Partners Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-45,000	Closed	-$2.76M	–	53
2017 Q4	$2.76M	Hold	45,000	–	–	2.39%	13
2017 Q3	$2.87M	Hold	45,000	–	–	2.57%	10
2017 Q2	$2.51M	Hold	45,000	–	–	2.3%	13
2017 Q1	$2.45M	Hold	45,000	–	–	1.82%	26
2016 Q4	$2.63M	Hold	45,000	–	–	2.1%	21
2016 Q3	$2.43M	Buy	+45,000	New	+$2.89M	1.36%	28

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opus Point Partners Management's BMY Position: Q3 2019 in Review

Opus Point Partners Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2019 at 33,000 shares worth $1.67M. The position accounts for 3.02% of the portfolio, ranked #5.

Opus Point Partners Management first reported a position in BMY in Q3 2015 and has held it in 13 quarters since. The position peaked at $5.74M in Q3 2017. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Opus Point Partners Management held 33,000 shares of Bristol-Myers Squibb worth $1.67M as of Q3 2019.
Opus Point Partners Management left its Bristol-Myers Squibb share count unchanged in Q3 2019.
Bristol-Myers Squibb made up 3.02% of Opus Point Partners Management's portfolio in Q3 2019, its #5 holding.
Opus Point Partners Management first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 13 quarters since.
Opus Point Partners Management's Bristol-Myers Squibb position peaked at $5.74M in Q3 2017.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.